Looking for a career in health economics and real-world evidence (RWE)? Check out the latest job openings in the pharmaceutical industry. There are many new opportunities available for RWE analysts, real-world evidence scientists, RWE managers, and real-world evidence market access managers in both pharmaceutical and life science consulting companies.
King of Prussia, PA, US. Möjligheten: Director, Reimbursement Strategy, ansvarar för att driva en framgångsrik omsättning av marknadstillträdes- och ersättningsstrategi till fältutförande för att optimera patienters tillgång och adoption av terapin. I rollen som strategisk ledare med ansvar för att stödja den verkställande ledningen och samarbeta med Field Reimbursement Managers (FRMs), identifierar denna roll ersättningstrender, tillträdeshinder och betalarutmaningar samtidigt som den utvecklar … Läs mer
Jakarta, Indokanesien. Indonesiens sjukvårdslandskap genomgår en betydande transformation som drivs av regeringens åtagande om universell hälsotäckning (Universal Health Coverage, UHC). Den senaste utvecklingen, inklusive ändringar i ersättningspolicyn, transformation av hälso- och sjukvårdstjänster, utvecklade kliniska vårdvägar och ett ökat fokus på kostnadseffektivitet, har skapat en mer komplex miljö för marknadstillträdesaktiviteter. Det ökande antalet interaktioner och samarbeten med externa intressenter, inklusive hälsoministeriet, … Läs mer
Horsham, PA, US / Titusville, NJ, US. Johnson & Johnson Health Care Systems Inc. rekryterar Director, Hematology Market Access Marketing till Strategic Customer Group (SCG). Denna tjänst är placerad i Horsham, PA och kommer att stödja affärsområdet Hematology Oncology Value, Access and Pricing. Strategic Customer Group ansvarar för utveckling och genomförande av strategier som säkerställer optimal … Läs mer
Tokyo, Japan. Avdelning: HEOR (hälsoekonomi & resultatforskning) Genom att utnyttja IQVIAs kärnresurser – medicinsk big data, Real World Data (RWD), avancerad analys och banbrytande teknik – främjar denna avdelning evidensgenerering genom hälsoekonomiska utvärderingar, Health Technology Assessments (HTA), marknadstillträdesstrategier, forskning om patientutfall och Real World Evidence (RWE)-studier. För denna tjänst söker vi en seniorkonsult eller chef som ska leda konsultverksamheten och … Läs mer
Petaling Jaya, Malaysia. Har du expertis inom och passion för att utveckla och implementera strategier för marknadstillträde? Vill du använda din expertis för att göra skillnad på ett företag som följer vetenskapen och förvandlar idéer till livsavgörande mediciner? Då kan AstraZeneca vara rätt för dig! Som Field Market Access Manager på AstraZeneca kommer du att driva hållbar … Läs mer
Durham, NC, US. Labcorp söker en Customer Marketing Manager för att bidra till att accelerera tillväxten av vår verksamhet inom Real World Data (RWD). Denna roll ansvarar för att utveckla integrerade marknadsföringsprogram samtidigt som den fungerar som en strategisk marknadsföringspartner till den kommersiella organisationen. Genom att arbeta nära teamen för produktledning, kommersiella frågor, medicin, digital marknadsföring, varumärke och analys kommer Customer Marketing Manager att utföra … Läs mer
Durham, NC, US. Jobböversikt IQVIA anställer en klinisk projektledare för att utöka vårt dedikerade Real World Evidence (RWE) FSP-team, med arbete helt inom miljön för ett framstående läkemedelsföretag. I denna roll kommer den kliniska projektledaren att ansvara för helhetsleveransen av projekt för realtidsbaserade observationsstudier inom det onkologiska terapiområdet. Det är viktigt för detta ... Läs mer
Cambridge, MA, US. The Director, Epidemiology and RWE Sciences will support pre- and post-launch evidence generating activities across all Oncology products. The role is responsible for leading the global evidence strategy and real‑world evidence generation for Ipsen’s oncology assets across the product lifecycle. This role provides scientific and strategic leadership to ensure that robust, fit‑for‑purpose RWE is generated to support … Läs mer
FÅ TILLGÅNG TILL 100% MED PRo
Fri tillgång upphör här
Du ser endast 30% roller, med en fördröjning på 7 dagar. Med Pro-versionen får du 100% av dem direkt. 357 öppna roller för Pro-medlemmar idag.
Real-world evidence (RWE) has become an increasingly important aspect of health economics research in recent years. It provides a comprehensive and in-depth understanding of how different health interventions work in real-world settings.
What is Real-World Evidence?
Real-world evidence (RWE) is defined as data collected from sources other than traditional randomized controlled trials (RCTs). These data come from a variety of sources, including electronic health records (EHRs), claims databases, registries, patient-reported outcomes (PROs), and surveys.
RWE allows researchers to evaluate the effectiveness, safety, and cost-effectiveness of health interventions in real-world settings. This is important because RCTs often have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations.
Importance of Real-World Evidence in Health Economics
RWE is becoming increasingly important in health economics because it provides a more complete picture of the effectiveness and safety of health interventions. By using RWE, researchers can evaluate how interventions work in a variety of settings and patient populations, which can help inform clinical practice and policy decisions.
RWE can also be used to conduct cost-effectiveness analyses, which help policymakers determine the value of health interventions. Cost-effectiveness analyses compare the costs and benefits of different health interventions, taking into account the costs of the intervention as well as the costs of any adverse events or complications that may occur.
Differences between RWE and Randomized Controlled Trials (RCTs)
RCTs are considered the gold standard for evaluating the effectiveness and safety of health interventions. However, there are several key differences between RWE and RCTs.
RCTs are conducted under controlled conditions and have strict inclusion and exclusion criteria, which means that the results may not be generalizable to real-world populations. RWE, on the other hand, is collected from a variety of sources and reflects the real-world experiences of patients.
RCTs also tend to be shorter in duration than RWE studies, which means that they may not capture the long-term effects of health interventions. RWE studies, on the other hand, can provide information on the long-term effectiveness and safety of interventions.
Methods of Collecting RWE
There are several methods of collecting RWE, including:
Electronic Health Records (EHRs) EHRs are digital records of patient health information that are maintained by healthcare providers. EHRs can provide a wealth of information on patient demographics, diagnoses, treatments, and outcomes.
Claims Databases Claims databases contain information on healthcare services and medications that are billed to insurance providers. Claims data can provide information on healthcare utilization, costs, and outcomes.
Registries Registries are databases that collect information on specific diseases or health conditions. They can provide valuable information on disease prevalence, treatment patterns, and outcomes.
Patient-Reported Outcomes (PROs) PROs are questionnaires or surveys completed by patients that assess their health status, symptoms, and quality of life. PROs can provide information on patient preferences and experiences with different interventions.
Surveys Surveys can be used to collect information on patient demographics, health behaviors, and healthcare utilization. They can also be used to assess patient preferences and satisfaction with different interventions.
Advantages of Real-World Evidence
There are several advantages of using RWE in health economics research, including:
RWE reflects real-world experiences and can provide a more comprehensive understanding of the effectiveness and safety of interventions.
RWE can be used to evaluate interventions in a variety of settings and patient populations.
RWE can provide information on the long-term effectiveness and safety of interventions.
RWE can be used to conduct cost-effectiveness analyses, which can inform clinical practice and policy decisions.
Challenges and Limitations of Real-World Evidence
There are several challenges and limitations to using RWE in health economics research, including:
RWE can be subject to bias and confounding, which can affect the validity of the results.
RWE can be difficult to collect and analyze, particularly when using multiple data sources.
RWE may not be as well-suited for evaluating rare diseases or interventions.
Applications of Real-World Evidence
RWE has several applications in health economics research, including:
Health Technology Assessment Health technology assessment (HTA) is a process that evaluates the clinical effectiveness, safety, and cost-effectiveness of new health technologies. RWE can be used in HTA to provide information on the real-world effectiveness and safety of interventions.
Comparative Effectiveness Research Comparative effectiveness research (CER) compares the effectiveness of different interventions for the same health condition. RWE can be used in CER to compare the effectiveness of interventions in different patient populations and settings.
Post-Marketing Surveillance Post-marketing surveillance is the process of monitoring the safety and effectiveness of new drugs and medical devices after they have been approved for use. RWE can be used in post-marketing surveillance to monitor the long-term safety and effectiveness of interventions.
Future of Real-World Evidence in Health Economics
RWE is likely to become increasingly important in health economics research in the future. Advances in technology and data analytics are making it easier to collect and analyze RWE, and policymakers are recognizing the importance of using RWE to inform clinical practice and policy decisions.
Looking for a career in health economics and real-world evidence (RWE)? Check out the latest job openings in the pharmaceutical industry. There are many new opportunities available for RWE analysts, real-world evidence scientists, RWE managers, and real-world evidence market access managers in both pharmaceutical and life science consulting companies.
Vi värdesätter din integritet. Vi använder cookies för att förbättra din upplevelse på vår webbplats, anpassa innehåll och annonser samt analysera vår trafik. Du kan välja vilka cookies du vill tillåta och du kan när som helst återkalla ditt samtycke. För mer information, se vår Policy för cookies.
